Mast Cell Tumors
Mast cell tumors (MCTs) are the foremost common malignant carcinoma in dogs, and significant variability exists in their biological behavior. Most MCTs are cured with appropriate local therapy, but a subset shows malignant behavior with the potential to spread to lymph nodes, liver, spleen, and other areas and thus become systemic cancer. due to this variable behavior, it’s difficult to predict how a person’s tumor goes to behave. The variability thus creates uncertainty choose what a specific dog’s prognosis is, whether staging tests to assess for metastasis is needed, and even what treatments are going to be necessary for the simplest outcome. additionally to controversies over the potential for the event of systemic disease or diffuse metastasis, controversies also exist over what treatment is required to best attain local control of those tumors. this text will briefly discuss the diagnosis of MCTs in dogs and can summarize the literature with regard to the controversial topics surrounding the more aggressive sort of this disease, with recommendations made supported by published studies.
